If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Reyvow ® (lasmiditan) tablets CV
50 mg, 100 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Is there a pregnancy registry for Reyvow® (lasmiditan)?
A Reyvow (lasmiditan) pregnancy registry is available for healthcare providers and patients.
Reyvow (lasmiditan) Pregnancy Registry Enrollment Information
Pregnancy Registry Will Monitor Pregnancy Outcomes With Lasmiditan Exposure
There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to lasmiditan during pregnancy.1
Enclosed Prescribing Information
The published references below are available by contacting 1-800-LillyRx (1-800-545-5979).
1Reyvow [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.
Date of Last Review: August 04, 2022